Human B. Lymphoblastoid cell, hybridoma, antibody and production of antibody
US5126259A · kind A · utility
20Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 1988 |
| Grant date | Jun 30, 1992 |
| Priority date | — |
| Expiry date | Dec 19, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides human B lymphoblastoid cell line AC-33, which is novel, and excellent in proliferativity and fusion capability, and works well as the parental line for obtaining a human monoclonal antibody-producing hybridoma. Said hybridoma possesses excellent proliferativity and stable antibody productivity, thus permitting efficient antibody production over a long period.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.